Welgene Biotech Co.,Ltd. (TPEX:6661)

Welgene Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	346.12	322.55	280.55	321.9	312.65	398.1
Revenue Growth (YoY)	15.95%	14.97%	-12.85%	2.96%	-21.46%	-4.64%
Cost of Revenue	199.31	186.71	160.83	180.1	179.38	235.8
Gross Profit	146.82	135.84	119.72	141.8	133.27	162.3
Selling, General & Admin	120.75	110.69	100.43	104.3	97.13	104.18
Research & Development	25.23	25.85	24.15	21.63	21.64	22
Operating Expenses	146.37	136.69	123.98	124.52	118.97	127.07
Operating Income	0.45	-0.85	-4.26	17.29	14.3	35.22
Interest Expense	-3.06	-2.97	-2.62	-0.28	-0.43	-0.65
Interest & Investment Income	1.9	1.46	1.46	0.51	0.17	0.21
Earnings From Equity Investments	-	-	-	-	-2.89	1.38
Currency Exchange Gain (Loss)	-1.34	0.25	0.01	-0.02	-	0.18
Other Non Operating Income (Expenses)	3.91	3	1.69	0.25	0.18	0.46
EBT Excluding Unusual Items	1.86	0.88	-3.73	17.74	11.34	36.8
Gain (Loss) on Sale of Investments	-	-	-	-4.19	5.04	-
Gain (Loss) on Sale of Assets	0.55	0.37	-0.11	-	0.21	0.33
Other Unusual Items	-	-	0.81	-	-	-
Pretax Income	2.42	1.25	-3.03	13.55	16.6	37.14
Income Tax Expense	0.78	0.54	0.11	4.01	2.89	7.36
Earnings From Continuing Operations	1.63	0.71	-3.15	9.54	13.7	29.78
Minority Interest in Earnings	0.67	0.4	0.5	0.01	-0	-0
Net Income	2.3	1.11	-2.65	9.55	13.7	29.77
Net Income to Common	2.3	1.11	-2.65	9.55	13.7	29.77
Net Income Growth	-	-	-	-30.29%	-53.98%	-3.55%
Shares Outstanding (Basic)	23	23	23	23	23	21
Shares Outstanding (Diluted)	23	23	23	23	23	21
Shares Change (YoY)	-	-	-0.10%	0.93%	10.99%	-0.01%
EPS (Basic)	0.10	0.05	-0.11	0.41	0.59	1.44
EPS (Diluted)	0.10	0.05	-0.11	0.41	0.59	1.43
EPS Growth	-	-	-	-30.53%	-58.74%	-3.38%
Free Cash Flow	59.16	51.27	-28.1	24.57	6.87	35.86
Free Cash Flow Per Share	2.54	2.20	-1.21	1.05	0.30	1.72
Dividend Per Share	-	-	-	0.180	0.480	1.102
Dividend Growth	-	-	-	-62.50%	-56.44%	-17.84%
Gross Margin	42.42%	42.11%	42.67%	44.05%	42.63%	40.77%
Operating Margin	0.13%	-0.27%	-1.52%	5.37%	4.57%	8.85%
Profit Margin	0.66%	0.34%	-0.94%	2.97%	4.38%	7.48%
Free Cash Flow Margin	17.09%	15.90%	-10.02%	7.63%	2.20%	9.01%
EBITDA	14.89	14.54	9.48	24.44	22.23	42.28
EBITDA Margin	4.30%	4.51%	3.38%	7.59%	7.11%	10.62%
D&A For EBITDA	14.44	15.39	13.74	7.15	7.93	7.05
EBIT	0.45	-0.85	-4.26	17.29	14.3	35.22
EBIT Margin	0.13%	-0.27%	-1.52%	5.37%	4.57%	8.85%
Effective Tax Rate	32.37%	43.52%	-	29.58%	17.43%	19.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.